Hyaluronic Acid Injection, or Hyaluronic Acid Dermal Fillers are the product can be used to smooth away wrinkles and fine line, create fuller and more accentuated lips, and adding facial volume and contour.
Due to the COVID-19 pandemic, the global Hyaluronic Acid Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, the Europe Hyaluronic Acid Injection market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Hyaluronic Acid Injection landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
In China markets, the core manufacturers of hyaluronic acid injection includes LG Life Sciences, Allergan, Beijing IMEIK etc and the top 5 companies hold a share about 75%.
This report focuses on Hyaluronic Acid Injection volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Hyaluronic Acid Injection market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and South Korea, etc.
Global Hyaluronic Acid Injection Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Single-phase Product
Duplex Product
Segment by Application
Skin Rejuvenation
Pad Face
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
LG Life Sciences
Allergan
Beijing IMEIK
Galderma
Bloomage BioTechnology
Haohai Biological Technology
Elravie (Humedix)
Medytox
Cleviel (Pharma Research Products)
HUGEL
Merz
Jingjia Medical Technology
Croma-Pharma GmbH
Sinclair
SciVision Biotech
Beijing Mengborun